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hospital during epidemic of enterovirus, we depend on our facility and abil-
ity of pediatric department to make up the strategies of enterovirus health-
care, which include the flexible administrative policy, the procedure and
education of infection control, and team work for serious complications.
Therefore, we could feel easy to face the challenge of this communicable
disease every year. We not only offer the high quality of healthcare but
also perform the effectiveness of infection control.PS 1-167
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Purpose: Klbesiella pneumoniae was Gram-negative bacteria caused a lot of
diseases, like pneumonia, and urinary tract infection. The rise of multidrug
resistance increased the difficult of treatment. Although tigecycline showed
activity against a broad spectrum of bacteria, the strains resistant to tigecy-
cline were emerged.
Methods: The whole genomes of both clinical strain and laboratory evolution
strainswere sequenced to identify the putativemutations related to tigecycline
resistance. Fitness cost measurement and transcriptome were also performed.
At last, complement experiment was perform to verify the gene’s function.
Results: The mutations in seven tigecycline resistant strains were observed
in ramR (5/7), lon (3/7), ramA (1/7) and rpsJ (1/7). The high fitness cost
was observed in laboratory evolution strains but not clinical strain. Of single
step evolution mutants, 80% (29/36) of mutants harbored mutation in ramR.
Five mutations were located in dimerization domain of RamR, and two mu-
tations were observed in DNA-binding domain. Furthermore, single step evo-
lution mutant demonstrated cross-resistance to ciprofloxacin.
Transcriptome analysis demonstrated ramR operon and acrA was high
expressed in all tigecycline resistant strains. Genes involved in nitrogen
metabolism were induced in laboratory evolution strains when compare
with wild type and clinical strain. Complement experiment showed that
both wild type ramR and lon partially restored the tigecycline sensitivity
of K. pneumoniae.Fig 1 Heatmap of the differentially expressed genes in one clinical strain and
six laboratory evolution strains.Conclusions: These results suggested that ramR operon and lon play a cen-
tral role in tigecycline resistance in K. pneumoniae.PS 1-168
ANALYSIS OF TIGECYCLINE’S CLINICAL USE FROM A MEDICAL CENTER IN
TAIWAN
Mei-Chun Lee a,e, Chun-Ming Lee b,c,d, Jen-Ai Lee e, Wei-Ying Lee a.
aDepartment of Pharmacy, Mackay Memorial Hospital, Taipei, Taiwan;
bDivision of Infectious Disease, Department of Medicine, Mackay Memorial
Hospital, Taipei, Taiwan; cMackay Junior College of Medicine, Nursing, and
Management, Taipei, Taiwan; dTaipei Medical University, Taipei, Taiwan;
eSchool of Pharmacy, College of Pharmacy, Taipei Medical University,
Taipei, Taiwan
Purpose: The growing numbers of multi-drug resistant organisms (MDRO)
usually lack effective antimicrobial agents so tigecycline has been given
great expectations as a candidate. The purpose of this study is to assess
the efficacy of tigecycline’s clinical use and its outcomes in hospitalized
patients.
Methods: We retrospectively reviewed the medical records of patients who
had received tigecycline at least for 3 days in our hospital from May 1, 2011
to January 31, 2013.
Results: Tree hundred and nine patients were analyzed in this study. Almost
half patients were shown to have successful clinical response to tigecycline
(151/309; 49%), with high clinical success observed in complicated skin and
skin structure infections (101/137; 74%). In failure group, treatment failure
was mostly seen in hospital-acquired pneumonias and pneumonias compli-
cated with bloodstream infections (83/100; 83%). The eradication rate for
totally bacterial isolates mostly collected from sputum was only 30% (33/
112). Four patients (1.3%) experienced from gastrointestinal adverse events
after the use of tigecycline. The mortality rate was 27% (84/309), which was
mainly due to pneumonias (48/101; 48%).
Conclusion: Our study showed good efficacy of tigecycline for the treatment
of complicated skin and skin structure infections with relatively lower
gastrointestinal adverse events. Regarding the treatment of pneumonia,
ineffective response was predictable as most patients with pneumonia
were hospital-acquired in our study.PS 1-169
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Purpose: Antibiotics-resisant Acinetobacter baumannii is a very important
cause of healthcare-associated infections, in addition to the highly patho-
genic and mortality, it is one of major healthcare-associated infecting path-
ogens. Integrons are the genetic unit that confer antibiotic resistance to
bacteria besides plasmid and transposon.
Methods: In this study, 100 A. baumannii clinical blood culture isolates were
collected from Show Chwan Memorial Hospital from 2008 to 2010 .The drug
susceptibility against 14 kinds of antibiotics were tested.The CS-PCR method
was used to detect the existence of class 1 integron.
Results: The drug resistance of A. baumannii to cephalosporins increased
significantly (54% up to 66%), and the resistance to PIP, TZP, SXT, SAM also
have an upward trend , but the drug resistance to aminoglycosides
decreased (60% down to 48%).And that was found 61.8% of these isolates
carried the class 1 integron, and the cassette arrays they carried were
only in 4 different sizes: 3.0 kb, 2.5 kb, 1.5 kb and 1.0 kb,among them
the isolates carrying 2.5 kb cassette array were at the highest percentage,
87.3%.This study also showed that A. baumannii isolates carrying integron
were more resistant to various antibiotics tested than non-integron-car-
rying isolates.
Conclusions: The widespread occurrence of 2.5 kb cassette array in A. bau-
mannii isolates from Show Chwan Memorial Hospital was rarely reported in
other countries.It is speculating that this phenomenon may be linked to
the preference of hospital to certain particular antibiotics, so that the A.
baumannii strains carrying 2.5-kb cassette array became dominant under
antibiotic selection pressure.
